Takeda Pharmaceutical Co Ltd ADR Financial Flexibility Index
Takeda Pharmaceutical Co Ltd ADR financial flexibility index. Takeda Pharmaceutical Co Ltd ADR (TAK) has a Financial Flexibility Index of 0.05x as of December 2025. Free cash flow of $402.60 Billion (operating CF $360.04 Billion minus capex $42.57 Billion) represents 0% of total liabilities ($7.77 Trillion). Explore Takeda Pharmaceutical Co Ltd ADR capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Takeda Pharmaceutical Co Ltd ADR (2001–2025)
Financial flexibility index of Takeda Pharmaceutical Co Ltd ADR from 2001 to 2025. Historical Financial Flexibility Index trend for Takeda Pharmaceutical Co Ltd ADR across 25 annual periods. Check how aggressively does Takeda Pharmaceutical Co Ltd ADR reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Takeda Pharmaceutical Co Ltd ADR Financial Flexibility Index by Year (2001–2025)
Takeda Pharmaceutical Co Ltd ADR financial flexibility index by year from 2001 to 2025. Year-by-year free cash flow to debt coverage for Takeda Pharmaceutical Co Ltd ADR. For the full cash flow conversion analysis, see TAK cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | $1.26 Trillion | $1.06 Trillion | $7.31 Trillion | ▲ +12.6% |
| 2024 | 0.15x | $1.20 Trillion | $716.34 Billion | $7.83 Trillion | ▼ -27.9% |
| 2023 | 0.21x | $1.61 Trillion | $977.16 Billion | $7.60 Trillion | ▲ +21.3% |
| 2022 | 0.17x | $1.31 Trillion | $1.12 Trillion | $7.49 Trillion | ▲ +8.3% |
| 2021 | 0.16x | $1.25 Trillion | $1.01 Trillion | $7.74 Trillion | ▲ +47.1% |
| 2020 | 0.11x | $887.46 Billion | $669.75 Billion | $8.09 Trillion | ▲ +106.4% |
| 2019 | 0.05x | $462.59 Billion | $328.48 Billion | $8.71 Trillion | ▼ -78.1% |
| 2018 | 0.24x | $506.12 Billion | $377.85 Billion | $2.09 Trillion | ▲ +56.2% |
| 2017 | 0.16x | $373.39 Billion | $261.36 Billion | $2.41 Trillion | ▲ +154.9% |
| 2016 | 0.06x | $110.35 Billion | $25.49 Billion | $1.81 Trillion | ▼ -56.3% |
| 2015 | 0.14x | $291.24 Billion | $182.52 Billion | $2.09 Trillion | ▲ +24.6% |
| 2014 | 0.11x | $226.85 Billion | $148.34 Billion | $2.03 Trillion | ▼ -52.0% |
| 2013 | 0.23x | $403.47 Billion | $307.71 Billion | $1.73 Trillion | ▼ -12.0% |
| 2012 | 0.26x | $398.47 Billion | $336.57 Billion | $1.51 Trillion | ▼ -61.9% |
| 2011 | 0.69x | $451.10 Billion | $326.94 Billion | $649.75 Billion | ▼ -2.3% |
| 2010 | 0.71x | $468.13 Billion | $381.17 Billion | $658.53 Billion | ▲ +37.3% |
| 2009 | 0.52x | $365.74 Billion | $326.27 Billion | $706.35 Billion | ▼ -16.1% |
| 2008 | 0.62x | $325.11 Billion | $292.50 Billion | $526.75 Billion | ▲ +58.3% |
| 2007 | 0.39x | $238.43 Billion | $209.28 Billion | $611.38 Billion | ▼ -33.3% |
| 2006 | 0.58x | $405.67 Billion | $373.57 Billion | $693.87 Billion | ▼ -8.9% |
| 2005 | 0.64x | $349.21 Billion | $295.54 Billion | $544.02 Billion | ▼ -2.5% |
| 2004 | 0.66x | $365.28 Billion | $311.12 Billion | $554.65 Billion | ▲ +9.0% |
| 2003 | 0.60x | $296.93 Billion | $263.45 Billion | $491.64 Billion | ▲ +9.9% |
| 2002 | 0.55x | $278.11 Billion | $240.59 Billion | $505.88 Billion | ▲ +14.2% |
| 2001 | 0.48x | $239.60 Billion | $212.66 Billion | $497.69 Billion | — |